TY - JOUR
T1 - Ultrasensitive analysis of the intestinal absorption and compartmentalization of aluminium in uraemic rats
T2 - A 26Al tracer study employing accelerator mass spectrometry
AU - Ittel, T. H.
AU - Steinhausen, C.
AU - Kislinger, G.
AU - Kinzel, S.
AU - Nolte, E.
AU - Sieberth, H. G.
PY - 1997/7
Y1 - 1997/7
N2 - Background. Developments in accelerator mass spectrometry (AMS) now permit the determination of femtogram amounts of 26Al1 in, blood and in various tissues with good precision and free of external contamination. Methods. In the present study we used trace quantities of 26Al to investigate the intestinal absorption and compartmentalization of aluminium in rats with renal failure (Nx, 5/6 nephrectomy) and in pair-fed controls (C). Single oral doses of 20 ng 26Al were administered to six animals in each group and, subsequently, 24-h post-load 26Al was analysed in serum, urine, bone, liver, and spleen by means of AMS. Results. Serum concentrations of 26Al were significantly lower in uraemic rats compared to controls, whereas urinary excretion was comparable (Nx, 7.11 ± 5.78 pg/day vs C, 9.46 ± 6.10 pg/day), suggesting a higher fraction of ultrafiltrable serum 26Al in uraemia. The target tissues of cellular transferrin-mediated 26Al uptake, liver and sleen, tended to show a larger degree of aluminium accumulation in controls (0.26 ± 0.31 pg/g vs Nx, 0.14 ± 0.10 pg/g and 0.37 ± 0.27 pg/g vs Nx, 0.25 ± 0.27 pg/g respectively). In contrast, in bone, a site of extracellular aluminium deposition, 26Al concentrations were more elevated in uraemia (1.22 ± 0.59 pg/g vs C: 0.68 ± 0.30 pg/g). Estimated total 26Al accumulation in all measured target tissues was significantly higher in uraemic rats (28.15 ± 9.90 pg vs C: 17.03 ± 7.03 pg) and total recovery of 26Al from tissue and urine was 26.58 ± 6.74 pg in controls and 35.75 ± 7.03 pg in uraemic animals, suggesting a fractional absorption of 0.133% and 0.175% respectively. Conclusions. Our data suggest that fractional absorption from a dietary level dose of 26Al is about 0.13%. Compartmentalization occurs in transferrin-dependent target tissues such as liver and spleen; however, in quantitative terms extracellular deposition in bone is more important. Uraemia has a significant effect on the intestinal absorption and compartmentalization of aluminium. It enhances fractional absorption and increases subsequent extracellular deposition of aluminium in bone. However, at the same time uraemia does not increase transferrin-dependent cellular accumulation of aluminium in liver and spleen.
AB - Background. Developments in accelerator mass spectrometry (AMS) now permit the determination of femtogram amounts of 26Al1 in, blood and in various tissues with good precision and free of external contamination. Methods. In the present study we used trace quantities of 26Al to investigate the intestinal absorption and compartmentalization of aluminium in rats with renal failure (Nx, 5/6 nephrectomy) and in pair-fed controls (C). Single oral doses of 20 ng 26Al were administered to six animals in each group and, subsequently, 24-h post-load 26Al was analysed in serum, urine, bone, liver, and spleen by means of AMS. Results. Serum concentrations of 26Al were significantly lower in uraemic rats compared to controls, whereas urinary excretion was comparable (Nx, 7.11 ± 5.78 pg/day vs C, 9.46 ± 6.10 pg/day), suggesting a higher fraction of ultrafiltrable serum 26Al in uraemia. The target tissues of cellular transferrin-mediated 26Al uptake, liver and sleen, tended to show a larger degree of aluminium accumulation in controls (0.26 ± 0.31 pg/g vs Nx, 0.14 ± 0.10 pg/g and 0.37 ± 0.27 pg/g vs Nx, 0.25 ± 0.27 pg/g respectively). In contrast, in bone, a site of extracellular aluminium deposition, 26Al concentrations were more elevated in uraemia (1.22 ± 0.59 pg/g vs C: 0.68 ± 0.30 pg/g). Estimated total 26Al accumulation in all measured target tissues was significantly higher in uraemic rats (28.15 ± 9.90 pg vs C: 17.03 ± 7.03 pg) and total recovery of 26Al from tissue and urine was 26.58 ± 6.74 pg in controls and 35.75 ± 7.03 pg in uraemic animals, suggesting a fractional absorption of 0.133% and 0.175% respectively. Conclusions. Our data suggest that fractional absorption from a dietary level dose of 26Al is about 0.13%. Compartmentalization occurs in transferrin-dependent target tissues such as liver and spleen; however, in quantitative terms extracellular deposition in bone is more important. Uraemia has a significant effect on the intestinal absorption and compartmentalization of aluminium. It enhances fractional absorption and increases subsequent extracellular deposition of aluminium in bone. However, at the same time uraemia does not increase transferrin-dependent cellular accumulation of aluminium in liver and spleen.
KW - Accelerator mass spectrometry
KW - Al tracer
KW - Compartmentalization
KW - Intestinal absorption
KW - Uraemia
UR - http://www.scopus.com/inward/record.url?scp=0030757103&partnerID=8YFLogxK
U2 - 10.1093/ndt/12.7.1369
DO - 10.1093/ndt/12.7.1369
M3 - Article
C2 - 9249771
AN - SCOPUS:0030757103
SN - 0931-0509
VL - 12
SP - 1369
EP - 1375
JO - Nephrology Dialysis Transplantation
JF - Nephrology Dialysis Transplantation
IS - 7
ER -